Projects per year
Metformin, developed from an ancient herbal remedy, remains the front-line drug for treatment of type 2 diabetes. Several targets to account for its therapeutic effects have been proposed, but a recent paper suggests a novel mechanism in which it antagonizes the cyclic AMP-dependent effects of glucagon on hepatic glucose production.
|Number of pages||2|
|Publication status||Published - 5 Mar 2013|
- Journal Article
FingerprintDive into the research topics of 'Metformin-Acting through Cyclic AMP as well as AMP?'. Together they form a unique fingerprint.
- 1 Finished
Non-canonical Pathways for Regulation of AMPK (Senior Investigator Award)
1/04/12 → 30/09/17